Skip to main content
. 2019 Jul 9;18(3):1823–1830. doi: 10.3892/etm.2019.7754

Figure 4.

Figure 4.

Gefitinib suppresses EMT via the Wnt/β-catenin signaling pathway in HeLa and Siha cells. The relative protein expression levels of GSK3β, p-GSK3β and β-catenin were determined by western blot analysis in (A) HeLa and (B) Siha cells following treatment with gefitinib. The activation of the Wnt/β-catenin pathway was determined by the luciferase reporter assay in (C) HeLa and (D) Siha cells following treatment with gefitinib. *P<0.05, **P<0.01 and ***P<0.001 vs. control. EMT, epithelial-mesenchymal transition; p-, phosphorylated.